as on October 17, 2025 at 10:41 pm IST
Day's Low
Day's High
1.16%
Downside
1.22%
Upside
52 Week's Low
52 Week's High
61.15%
Downside
118.49%
Upside
Check Dyne Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.3B
EPS (TTM)
-3.6563
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0.19
EBITDA
-439.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
65547400.00%
Compare market cap, revenue, PE, and other key metrics of Dyne Therapeutics, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.3B | -5.74% | NA | 0.00% | |
BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
NA | $35.8B | NA | NA | -3.89% | |
BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
BUY | $61.1B | -5.1% | 14.53 | 31.37% |
The Dyne Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dyne Therapeutics, Inc investment value today
Current value as on today
₹52,049
Returns
Returns from Dyne Therapeutics, Inc Stock
Dollar Returns*
₹4,914 (+4.91%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Dyne Therapeutics, Inc. Average target price of $34.53
Get share price movements and forecasts by analysts on Dyne Therapeutics, Inc.
What analysts predicted
52.59%UPSIDE
Target Price
$34.53
Current Price
$16.37
Analyzed by
13 Analysts
Target
$34.53
Dyne Therapeutics, Inc target price $34.53, a slight upside of 52.59% compared to current price of $16.37. According to 13 analysts rating.
Investment in Dyne Therapeutics, Inc Shares on INDmoney has grown by 266.66% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:266.66% versus previous 30 day period
Search interest for Dyne Therapeutics, Inc Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:58% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, DYN stock has moved up by 16.9%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 114.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 120.4%
Organisation | Dyne Therapeutics, Inc |
Headquarters | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Industry | Commercial Services |
CEO | Mr. John G. Cox M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Oxana Beskrovnaya Ph.D. | Chief Innovation Officer |
Dr. Douglas Kerr M.B.A., M.D., Ph.D. | Chief Medical Officer |
Dr. Rajesh Manchanda Ph.D. | Chief Technical Officer |
Mr. James P. Bilotta M.B.A. | Chief Digital & Information Officer |
Dr. Ranjan Batra Ph.D. | Chief Scientific Officer |
Mr. Daniel Wilson | Senior VP & Head of Legal |
Ms. Lucia Celona | Chief Human Resource Officer |
Mr. John G. Cox M.B.A. | CEO, President & Director |
Ms. Johanna Friedl-Naderer | Chief Commercial Officer |
Mr. Erick J. Lucera C.F.A., CPA | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer |
Dyne Therapeutics, Inc share price today is $16.37 as on . Dyne Therapeutics, Inc share today touched a day high of $16.57 and a low of $16.18.
Dyne Therapeutics, Inc share touched a 52 week high of $35.77 on and a 52 week low of $6.36 on . Dyne Therapeutics, Inc stock price today i.e. is trending at $16.37,which is 54.23% down from its 52 week high and 157.39% up from its 52 week low.
Dyne Therapeutics, Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Dyne Therapeutics, Inc (DYN) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Dyne Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dyne Therapeutics, Inc share’s latest price of $16.37 as on October 17, 2025 at 10:41 pm IST, you will get 0.6109 shares of Dyne Therapeutics, Inc. Learn more about
fractional shares .
Dyne Therapeutics, Inc stock has given -5.74% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?